Blood Disorders: Diagnosis, Management, and Future Opportunities
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Hematology".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 27
Special Issue Editors
Interests: leukemia and cancer; molecular mechanisms; TKI resistance; Dictyostelium discoideum model organism
Special Issues, Collections and Topics in MDPI journals
Interests: ubiquitination system; chemotaxis and aerotaxis; omics science; simple model; leukemia and cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We invite researchers and clinicians to contribute to this Special Issue, which will focus on the critical need to translate scientific advancements into clinical practice, to ultimately improve patient outcomes and quality of life.
Blood disorders encompass a wide range of conditions affecting the blood's ability to function correctly. These disorders can impact red blood cells (e.g., anemia and hemophilia), white blood cells (e.g., leukemia and lymphoma), platelets (e.g., thrombocytopenia), and plasma (e.g., multiple myeloma), leading to various health issues.
From both a biological and clinical perspective, we will explore the major current challenges and opportunities, from the use of flow cytometry, digital droplet PCR (ddPCR), and next-generation sequencing (NGS) to new, attractive metabolomic approaches to identifying emerging biomarkers. All these methods are crucial to explore further due to their potential in early detection, prognosis, and optimal treatment.
In this Special Issue, with contributions from experts, we aim to discuss and clarify the most important technological advancements in diagnosis and the identification of novel biomarkers, highlighting the impact that they could have on early detection and personalized treatment approaches.
Dr. Cristina Panuzzo
Dr. Barbara Pergolizzi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- blood disorders
- biomarkers
- personalized medicine
- diagnosis
- NGS
- metabolomics
- digital droplet PCR (ddPCR)
